Items where authors include "Shaw, P."

Article

Alarcan, H. orcid.org/0009-0002-8788-2773, Bruno, C., Emond, P. et al. (20 more authors) (2024) Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis. Annals of the New York Academy of Sciences, 1536 (1). pp. 82-91. ISSN 0077-8923

Lombardo, F.L. orcid.org/0000-0001-6183-0735, Spila Alegiani, S., Mayer, F. et al. (93 more authors) (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials, 24 (1). 792. ISSN 1468-6708

Castelli, L.M., Lin, Y.-H., Sanchez-Martinez, A. et al. (19 more authors) (2023) A cell-penetrant peptide blocking C9ORF72-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins. Science Translational Medicine, 15 (685). ISSN 1946-6234

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

Shaw, P. orcid.org/0000-0002-8925-2567, Miller, T., Cudkowicz, M. et al. (7 more authors) (2022) Tofersen in adults with SOD1-ALS: phase 3 VALOR trial and open-label extension results. Journal of Neurology, Neurosurgery & Psychiatry, 93 (9). e2. ISSN 0022-3050

White, S., Zarotti, N., Beever, D. orcid.org/0000-0001-9063-3677 et al. (22 more authors) (2021) The nutritional management of people living with Amyotrophic Lateral Sclerosis (ALS): A national survey of dietitians. Journal of Human Nutrition and Dietetics, 34 (6). pp. 1064-1071. ISSN 0952-3871

Fennell, D.A., Ewings, S., Ottensmeier, C. et al. (36 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. The Lancet Oncology, 22 (11). pp. 1530-1540. ISSN 1470-2045

Sassani, M., Alix, J., McDermott, C. et al. (6 more authors) (2020) Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain, 143 (12). pp. 3603-3618. ISSN 0006-8950

Zarotti, N. orcid.org/0000-0002-8129-6151, Coates, E., McGeachan, A. et al. (22 more authors) (2019) Health care professionals’ views on psychological factors affecting nutritional behaviour in people with motor neuron disease : a thematic analysis. British Journal of Health Psychology, 24 (4). pp. 953-969. ISSN 1359-107X

Al-Chalabi, A., Shaw, P. orcid.org/0000-0002-8925-2567, Leigh, P.N. et al. (6 more authors) (2019) Oral levosimendan in amyotrophic lateral sclerosis : a phase II multicentre, randomised, double-blind, placebo-controlled trial. Journal of Neurology, Neurosurgery & Psychiatry, 90 (10). pp. 1165-1170. ISSN 0022-3050

Weeks, K., Gould, R., McDermott, C. et al. (13 more authors) (2019) Needs and preferences for psychological interventions of people with motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20 (7-8). pp. 521-531. ISSN 2167-9223

Allen, S., Hall, B., Castelli, L. et al. (19 more authors) (2019) Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain, 142 (3). pp. 586-605. ISSN 0006-8950

Ferraiuolo, L. orcid.org/0000-0001-9118-5714 and Shaw, P. orcid.org/0000-0002-8925-2567 (2018) Lost in translation: microRNAs mediate pathological cross-talk between motor neurons and astrocytes. Brain, 141 (9). pp. 2534-2536. ISSN 0006-8950

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Jenkins, T., Alix, J. orcid.org/0000-0001-8391-9749, David, C. et al. (10 more authors) (2018) Imaging muscle as a potential biomarker of denervation in motor neuron disease. Journal of Neurology, Neurosurgery and Psychiatry, 89. pp. 248-255. ISSN 0022-3050

Waller, R. orcid.org/0000-0001-5815-8829, Wyles, M., Heath, P.R. et al. (4 more authors) (2018) Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Frontiers in Neuroscience, 11. 731. ISSN 1662-4548

Al-Chalabi, A. orcid.org/0000-0002-4924-7712, Andersen, P.M., Chandran, S. et al. (38 more authors) (2017) July 2017 ENCALS statement on edaravone. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18 (7-8). pp. 471-474. ISSN 2167-8421

Dolzhenko, E., van Vugt, J.J.F.A., Shaw, R.J. et al. (42 more authors) (2017) Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Research , 27. pp. 1895-1903. ISSN 1088-9051

Waller, R. orcid.org/0000-0001-5815-8829, Goodall, E.F., Milo, M. et al. (8 more authors) (2017) Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiology of Aging, 55. pp. 123-131. ISSN 0197-4580

Webster, C., Smith, E., Shaw, P. et al. (1 more author) (2017) Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? Frontiers in Molecular Neuroscience, 10. 123. ISSN 1662-5099

Oeckl, P., Jardel, C., Salachas, F. et al. (32 more authors) (2016) Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. pp. 1-10. ISSN 2167-8421

Hobson, E.V. orcid.org/0000-0002-8497-2338, Baird, W., Cooper, C. et al. (3 more authors) (2016) Using technology to improve access to specialist care in amyotrophic lateral sclerosis: A systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17 (5-6). pp. 313-324. ISSN 2167-8421

Tian, X., Nyberg, S., Sharp, P.S. et al. (8 more authors) (2015) LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Scientific Reports, 5. 11990. ISSN 2045-2322

Agosta, F., Al-Chalabi, A., Filippi, M. et al. (9 more authors) (2014) The El Escorial criteria: Strengths and weaknesses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16 (1-2). pp. 1-7. ISSN 2167-8421

Law, J., Shaw, P., Earland, K. et al. (2 more authors) (2014) A psychology based approach for longitudinal development in cognitive robotics. Frontiers in Neurorobotics, 8. ARTN 1. ISSN 1662-5218

Earland, K., Lee, M., Shaw, P. et al. (1 more author) (2014) Overlapping Structures in Sensory-Motor Mappings. PLoS ONE, 9 (1). e84240. ISSN 1932-6203

Conference or Workshop Item

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.

Proceedings Paper

Greystoke, A., Oughton, J.B., Brown, S.R. et al. (16 more authors) (2024) Olaparib, AZD1390, ceralasertib, saruparib and consolidation durvalumab (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer (NSCLC). In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. ASCO Publications .

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier , S296-S297.

Sassani, M., Alix, J. orcid.org/0000-0001-8391-9749, Mcdermott, C. et al. (7 more authors) (2021) Brain energy metabolism in ALS : a phosphorus-31 magnetic resonance spectroscopy study. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2021), 03-07 Oct 2021, Rome, Italy. Elsevier BV , p. 119412.

Bell, S., De Marco, M., Barnes, K. et al. (5 more authors) (2020) Do deficits in mitochondrial spare respiratory capacity contribute to neuropsychological changes seen in Alzheimer's disease? In: Neurology. UNSPECIFIED. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology .

Jenkins, T., Alix, J. orcid.org/0000-0001-8391-9749, Rao, G. et al. (8 more authors) (2017) Imaging denervation in motor neuron disease for future clinical trials: a longitudinal cohort study. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2017), 16-21 Sep 2017, Kyoto, Japan. https://doi.org/10.1016/j.jns.2017.08.328, 381s . Elsevier , p. 102.

Hewamadduma, C.A., Omalley, R., Robinson, M. et al. (7 more authors) (2017) Mutations in SPG7 as an important cause of spastic-ataxia in a large british cohort: Hybrid phenotype helps direct screening. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2017), 16-21 Sep 2017, Kyoto, Japan. Elsevier , pp. 304-305.

Rafiq, M., Proctor, A., McDermott, C. et al. (1 more author) (2015) Screening for respiratory failure in ALS using clinical questioning, respiratory function tests and transcutaneous carbon dioxide: which is the better tool? In: Journal of Neurology, Neurosurgery and Psychiatry. 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London. .

Rafiq, M., Lee, E., Bradburn, M. et al. (2 more authors) (2015) Elevated creatine kinase is associated with a better prognosis in patients with amyotrophic lateral sclerosis. In: Neurology. AAN 67th Annual Meeting, 18-24 Apr 2015, Washington D.C.. American Academy of Neurology , p. 741.